Follikuláris limfóma: vizsgálatok itt: Olaszország
25 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleEvaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
- Where
- Brescia, Meldola, Milan, Naples, Rozzano
- Életkor
- 18 év and over
- People
- 130 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06806033 · EU 2024-516791-15-00 - 1/2. fázisTaking peopleA Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
- Where
- Candiolo, Milan, Naples, Reggio Emilia, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 280 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07519772 · EU 2025-523005-15-00 - 2/3. fázisTaking peopleA Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
- Where
- Candiolo, Rome
- Életkor
- 18 év and over
- People
- 960 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07634471 · EU 2025-522777-10-00 - 1. fázisTaking peopleA Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Where
- Bologna, Naples, Rozzano
- Életkor
- 18 év and over
- People
- 215 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07101328 · EU 2025-524180-20-00 - 1. fázisTaking peopleA Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Where
- Bologna, Milan
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07226843 · EU 2025-523601-16-00 - 1. fázisTaking peopleIKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
- Where
- Candiolo, Milan
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Iksuda Therapeutics Ltd.
See details and how to joinNCT05365659 - 1. fázisTaking peopleA Study of ARC-02 in B-cell NHL
- Where
- Aviano, Bergamo, Bologna, Rozzano
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT07691606 · EU 2026-525606-35-00 - 3. fázisTaking peopleA Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- Where
- Bologna, Guastalla, Milan, Rozzano, Trieste
- Életkor
- 18 év to 130 év
- People
- 1018 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06549595 · EU 2023-510098-33-01 - 2. fázisTaking peopleSurovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Where
- Alexandria, Bologna, Busto Arsizio, Milan
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00 - 3. fázisTaking peopleA Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
- Where
- Aviano, Bologna, Brescia, Candiolo, Genoa, Meldola, Milan, Modena, Monza, Naples, Novara, Pavia, Perugia, Ravenna, Reggio Emilia, Rome, Turin, Udine
- Életkor
- 18 év and over
- People
- 580 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06149286 · EU 2022-503092-28-00 - 3. fázisTaking peopleA Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
- Where
- Ascoli Piceno, Bologna, Brescia, Candiolo, Genoa, Meldola, Milan, Naples, Novara, Ravenna, Tricase, Udine, Varese
- Életkor
- 18 év and over
- People
- 822 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06091254 · EU 2022-502660-20-00 - 1/2. fázisTaking peopleA Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Where
- Bologna, Milan, Roma, Verona
- Életkor
- 18 év and over
- People
- 689 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00 - 1/2. fázisTaking peopleA Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
- Where
- Bologna, Milan
- Életkor
- 18 év and over
- People
- 174 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06542250 - 3. fázisTaking peopleComparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi
- Where
- Alessandria, Avellino, Aviano, Bari, Biella, Brescia, Cagliari, Candiolo, Castelfranco Veneto, Catania, Cuneo, Florence, Ivrea, Latina, Meldola, Messina, Milan, Modena, Monza, Naples, Novara, Padova, Palermo, Pavia, Perugia, Piacenza, Pisa, Ravenna, Reggio Emilia, Rimini, Roma, Sassuolo, Siena, Sondrio, Terni, Treviso, Udine, Varese, Verona
- Életkor
- 18 év and over
- People
- 190
- Run by
- Fondazione Italiana Linfomi - ETS
See details and how to joinNCT05929222 - 2. fázisTaking peopleCombining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
- Where
- Bologna, Milan, Naples
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Universität Münster
See details and how to joinNCT07197307 · EU 2023-509861-19-01 - 1. fázisTaking peopleA Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- Where
- Bologna, Brescia, Milan, Rome
- Életkor
- 18 év and over
- People
- 572 worldwide
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT05131022 · EU 2023-510541-25-00 - 3. fázisTaking peoplePhase III trial comparing local radiotherapy alone or with Obinutuzumab in early stage Follicular Lymphoma: the GAZEBO Trial.
- Where
- Alexandria, Avellino, Aviano, Bari, Brescia, Cagliari, Candiolo, Castelfranco Veneto, Catania, Chivasso, Cuneo, Florence, Latina, Meldola, Messina, Milan, Modena, Monza, Naples, Novara, Padova, Palermo, Pavia, Perugia, Piacenza, Pisa, Ponderano, Ravenna, Reggio Emilia, Rimini, Roma, Rome, Sassuolo, Siena, Sondrio, Terni, Treviso, Udine, Varese, Verona
- Életkor
- 18 év and over
- People
- 190
- Run by
- Fondazione Italiana Linfomi Onlus
See details and how to join2022-502775-29-01 · EU 2022-502775-29-01 - 2. fázisTaking peopleEfficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
- Where
- Turin
- Életkor
- 18 év to 70 év
- People
- 213 worldwide
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT04844866 · EU 2023-506270-13-00 - 3. fázisTaking peopleA Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
- Where
- Alexandria, Bologna, Meldola, Naples, Pisa, Rozzano, Turin
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Celgene
See details and how to joinNCT06911502 · EU 2024-519152-82-00 - No phaseNot yet taking people in OlaszországGeriatric-guided Care Versus Conventional Care in Elderly Unfit/Frail Patients With Diffuse Large B-cell Lymphoma in First Line Treatment
- Where
- Ancona, Avellino, Aviano, Bari, Brescia, Cagliari, Florence, Milan, Monza, Padova, Palermo, Parma, Piacenza, Prato, Ravenna, Reggio Emilia, Roma, Siena, Teramo, Torino, Udine, Verona
- Életkor
- 70 év and over
- People
- 170
- Run by
- Fondazione Italiana Linfomi - ETS
See details and how to joinNCT07476105 - No phaseTaking peopleReal-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
- Where
- Bari, Milan, Naples, Palermo, Rome, Turin
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- AbbVie
See details and how to joinNCT06830759 - 1. fázisTaking peopleStudy of SGR-1505 in Mature B-Cell Neoplasms
- Where
- Alexandria, Milan, Turin, Verona
- Életkor
- 18 év and over
- People
- 98 worldwide
- Run by
- Schrödinger, Inc.
See details and how to joinNCT05544019 · EU 2023-505204-34-00 - No phaseTaking peopleStudy to Evaluate the Response to Treatment With Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma (FL) After at Least Two Lines of Therapy, Within the Compassionate Use Program (CUP).
- Where
- Milan
- Életkor
- 18 év and over
- People
- 25
- Run by
- Andrés José Maria Ferreri
See details and how to joinNCT07278921 - No phaseTaking peopleMultilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational Study From FIL_FOLL12 Trial
- Where
- Alessandria, Biella, Brescia, Catania, Cuneo, Florence, Genova, Meldola, Milan, Modena, Monza, Novara, Pagani, Palermo, Pavia, Piacenza, Reggio Calabria, Rimini, Roma, Rozzano, Torino, Tricase, Udine, Varese
- Életkor
- 18 év and over
- People
- 654
- Run by
- Fondazione Italiana Linfomi - ETS
See details and how to joinNCT05816850 - No phaseTaking peopleItalian Observational Study on CAR-T Therapy for Lymphoma
- Where
- Milan
- Életkor
- 18 év and over
- People
- 5300
- Run by
- Paolo Corradini
See details and how to joinNCT06339255